IBRNvsLABU
iShares Neuroscience and Healthcare ETF against DIREXION DAILY S&P BIOTECH BULL 3X SHARES — the fee, the flows, the book, and a year head-to-head.
Head to head
| IBRN | LABU | |
|---|---|---|
| Expense ratio | 0.47% | — |
| Assets | $7864.21T | $674M |
| Net flow, 1 month | +$2M | −$30M |
| Net flow, 1 year | +$2M | −$1.1B |
| Return, YTD | +24.7% | +101.4% |
| Return, 1 year | +57.5% | +339.6% |
| Avg daily volume | 3K | 413K |
| Holdings | 54 | 134 |
| Listed | Aug 23, 2022 | Nov 26, 2023 |
| Options market | Yes | Yes |
MARKED CELLS LEAD ON THAT LINE · LOWER FEE, LARGER ASSETS, STRONGER FLOWS & RETURNS